DCF — MUSC HEALTH CHESTER MEDICAL CENTER
Enterprise Value: $-153.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-153.2M
Enterprise Value
$-47.2M
PV of Cash Flows
$-106.0M
PV of Terminal Value
$-170.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $58.2M | $-10.2M | -18.0% | $-12.7M | $-11.5M |
| Year 2 | $59.9M | $-9.9M | -17.0% | $-12.5M | $-10.3M |
| Year 3 | $61.7M | $-9.6M | -16.0% | $-12.2M | $-9.2M |
| Year 4 | $63.6M | $-9.6M | -15.0% | $-12.3M | $-8.4M |
| Year 5 | $65.5M | $-9.7M | -15.0% | $-12.5M | $-7.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-153.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$56.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.18095024662386153
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5